Влияние фенсукцинала на липидный обмен, перекисное окисление липидов и активность антиоксидантной системы кроликов с дитизоновым диабетом

Н. И. Горбенко, В В Полторак, А. И. Гладких et al. · Экспериментальная и клиническая фармакология · 2003

A three-month administration of phensuccinal improved glucose homeostasis, decreased the levels of total cholesterol, triglycerides, fatty acids, and low-density lipoproteins in the blood serum, and reduced the lipid peroxidation rate as compared to the untreated diabetic control. In addition, phensuccinal increased the content of the antiatherogenic high-density lipoprotein fraction and the related paraoxonase enzyme activity. The preventive effect of phensuccinal with respect to diabetic dyslipidemia development, together with the antioxidant action, show this compound to be a promising therapeutic means of preventing and/or reducing macrovascular complications in diabetic patients.

Cited by 0 works.

Authors